Skip to main content
MRK logo

MRK · Merck & Co., Inc. · Share Buybacks

Track MRK — free
Market Cap
$364.26B
Shares
2.47B
Volume · Nov 13 6.51M Avg daily vol (3M) 10.22M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$10,000,000,000
as of 2025-01-01 · from 10-Q (reviewed)
Remaining Authorization
$5,700,000,000
as of 2026-06-30 · from 10-Q (reviewed)
Program Utilization
43.0% $4,300,000,000 used of $10,000,000,000
Program Announced Authorized Remaining Runs Through
2025-01-01 $10,000,000,000 $5,700,000,000 —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it (on today's share basis). Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $2,284,000,000
2025-12-31 $5,084,000,000
2024-12-31 $1,306,000,000
2023-12-31 $1,346,000,000
2022-12-31 $0
2021-12-31 $840,000,000
2020-12-31 $1,281,000,000
2019-12-31 $4,780,000,000
2018-12-31 $9,091,000,000
2017-12-31 $4,014,000,000
2016-12-31 $3,434,000,000
2015-12-31 $4,186,000,000
2014-12-31 $7,703,000,000
2013-12-31 $6,516,000,000
2012-12-31 $2,591,000,000
2011-12-31 $1,921,000,000
2010-12-31 $1,593,000,000
2009-12-31 $0
2008-12-31 $2,725,000,000
2007-12-31 $1,429,700,000

Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.

Key facts CIK 310158 CUSIP 58933Y105 13F (30d) 3112 filings 2970 filers Visit website Investor relations